Myelodysplastic Syndromes (MDS)
The myelodysplastic syndromes (MDS, formerly known as preleukemia) are a diverse collection of hematological (blood-related) medical conditions that involve ineffective production (or dysplasia) of the myeloid class of blood cells.
Patients with MDS often develop severe anemia and require frequent blood transfusions. In most cases, the disease worsens and the patient develops cytopenias (low blood counts) due to progressive bone marrow failure. In about one third of patients with MDS, the disease transforms into acute myelogenous leukemia (AML), usually within months to a few years.
Myelodysplastic syndromes (MDS) are a group of diseases that affect the bone marrow and blood. Some types of MDS are mild and easily managed, while other types are severe and life-threatening. Mild MDS can grow more severe over time. It can also develop into a fast-growing, severe leukemia called acute myelogenous leukemia.
What is preleukemia or MDS?
"Good Morning America's" Robin Roberts announced this morning that she has myelodysplastic syndrome, or MDS. The rare syndrome is also known as preleukemia.
MDS can be broken down by its name: Myeloid refers to a type of blood cell; dysplasia means a problem with the development of those cells.
The condition occurs when "something goes wrong in your bone marrow — the spongy material inside your bones where blood cells are made," according to the Mayo Clinic.
Causes of MDS
In MDS, the bone marrow does not make enough normal blood cells for the body. One, two or all three types of blood cells — red blood cells, white blood cells and platelets — may be affected. The marrow may also make immature cells called blasts. Blasts normally develop into red blood cells, white blood cells or platelets. In MDS, the blasts are abnormal and do not develop or function normally.Myelodysplastic syndromes, molecular devices, mds process, mds, myelodysplastic, mds causes, defination of mds, derive myelodysplastic syndromes.
0 comments:
Post a Comment